All articles tagged with #pharma
Originally Published 3 days ago — by The Economist
AI is significantly improving the pharmaceutical industry by addressing the high failure rate and lengthy, costly process of drug development, which can take over a decade and cost nearly $3 billion per successful drug.
Originally Published 24 days ago — by statnews.com
Employers like HCA Healthcare are dropping coverage for weight loss drugs such as Zepbound and Wegovy due to rising costs and are directing employees to manufacturer discount programs, which may be cheaper than insurance coverage. The growth of direct-to-consumer programs by pharma companies Eli Lilly and Novo Nordisk is contributing to this shift, potentially making these drugs less affordable for the general public despite expanding access.
Originally Published 26 days ago — by statnews.com
The article highlights the outstanding CEOs of 2025 in the biotech and pharma industries, emphasizing a record year for mergers and acquisitions, with nearly $240 billion in deals, and recognizing various leaders including dealmakers, underdogs, and mavericks.
Originally Published 2 years ago — by Barron's
Moderna's stock is experiencing its best single-day performance in over a year, largely due to an analyst at Oppenheimer upgrading the stock. This positive shift comes after a challenging 2023 for the company, suggesting a potentially more favorable outlook for Moderna in the current year.
Originally Published 2 years ago — by The New York Times
Israel has issued warnings to more residents in Gaza to evacuate as the conflict with Hamas continues, while the Israeli Supreme Court is set to hear a case involving the country's pharmaceutical industry.
Originally Published 2 years ago — by CNBC
As the stock market opens on Tuesday, investors are cautious amid a mixed session on Monday and the surging yield on the 10-year Treasury note. Microsoft CEO Satya Nadella testified in federal court, accusing Google of monopolizing the online search market. Pharma companies have agreed to participate in the first round of Medicare drug price negotiations. Flexport, a supply chain management platform, experienced internal strife as CEO Dave Clark clashed with the founder. Rep. Matt Gaetz filed a motion to oust House Speaker Kevin McCarthy, following a short-term spending deal.
Originally Published 2 years ago — by The Wall Street Journal
Drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss, with social media hype around drugs like Ozempic and Mounjaro exploding. More than 40% of American adults are obese, making it a massive target market for pharmaceutical companies. However, concerns have been raised over the side effects of these drugs and the fact that they need to be taken indefinitely.
Originally Published 2 years ago — by CNN
Commercial real estate is facing a crisis due to the pandemic, with many businesses struggling to pay rent and vacancies increasing. Meanwhile, former Treasury Secretary Larry Summers warns of rising inflation, and an ex-Fed official argues for continued interest rate hikes. The CEO of a pharma giant explains why they are cutting the cost of insulin. A journalist shares a creepy encounter with new technology, and CNN tries out an AI flirt app with shocking results.